Strong Sales Growth
Abbott delivered high single-digit sales growth excluding COVID testing, with a 7.5% increase in the second quarter and an 8% increase in the first half of 2025.
Record Performance in EPD
Sales in EPD grew nearly 8% in the quarter, surpassing $1 billion in quarterly sales for the first time, driven by strong performance in key markets including India, China, and other regions.
Medical Devices Success
Medical Devices sales grew 12% driven by double-digit growth in diabetes care, heart failure, structural heart, electrophysiology, and cardiac rhythm management.
Diabetes Care Growth
Sales of continuous glucose monitors reached $1.9 billion in the quarter, growing 19.5%.
EPS Growth
Second quarter adjusted earnings per share were $1.26, reflecting 11% growth versus the prior year and 16% growth on a sequential basis.